Ex parte JANOFF et al. - Page 2


              Appeal No. 2001-1245                                                                                     
              Application 08/430,661                                                                                   
                     (c)    combining the product of step (a) and the product of step (b) so as to                     
                     obtain a mixture of the lipid solution and the agent solution;                                    
                     (d)    adding an aqueous phase to the product of step (c); and                                    
                     (e)    removing organic solvent from the mixture of step (d),                                     
                     wherein the complex has no captured volume, wherein the complex is                                
                     substantially free of liposomes and wherein the relative amount of polyene                        
                     antifungal agent used is such that the agent comprises from about 25 to 50 mole                   
                     percent of the complex.                                                                           
                     The references relied upon by the examiner are:                                                   
              Fukushima et al. (Fukushima)              4,687,762                  Aug. 18, 1987                      
              Moro et al. (Moro)                       GB 2041871A                 Sep. 17, 1980                      
              Heyne1                                  EP 0,069,307                Jan. 12, 1983                      

                     Claims 77 through 81, 83 through 85, 89, 91 and 92 stand rejected under 35                        
              U.S.C. § 103(a).  As evidence of obviousness, the examiner relies upon Fukushima by                      
              itself or Fukushima and Moro or Fukushima and Heyne.  We reverse.                                        


                                                   BACKGROUND                                                          
                     As seen from claim 77, the claimed invention is directed to a method of preparing                 
              a drug-lipid complex which comprises a series of five steps.  The complex contains a                     
              polyene antifungal agent and a lipid which comprises a fatty acid or a phospholipid.  As                 
              explained in the last clause of claim 77, the complex has no captured volume, is                         
              substantially free of liposomes and the relative amount of polyene antifungal agent used                 
              in the method is such that the agent comprises from about 25 to 50 mole percent of the                   
              complex.                                                                                                 

                                                                                                                       
              1 The record copy of this document is in the German language.  For reasons unclear from the record, the  
              examiner did not request a translation of the document and was satisfied to consider its disclosure on the
              basis of the English language abstract attached thereto.  Appellants attached a translation of the       
              underlying European Patent Application to the Reply Brief.  Our consideration of the issues on appeal has
              been based upon the full text translation supplied by appellants to whom we express our appreciation.    

                                                          2                                                            



Page:  Previous  1  2  3  4  5  6  7  8  9  Next 

Last modified: November 3, 2007